大脑粉样蛋白升高与认知正常人的认知衰退之间的关联
Michael C Donohue1, Reisa A Sperling2, Ronald Petersen3
1Alzheimer's Therapeutic Research Institute, Department of Neurology, University of Southern California, San Diego.
JAMA
|June 14, 2017
概括
在认知正常的个体中,脑粉样蛋白的升高与阿尔茨海默氏症相关认知衰退的风险增加有关. 需要进一步的研究来证实临床意义和长期影响.
科学领域:
- 神经科学
- 老年学
- 生物标志物
背景情况:
- 在认知正常的个体中,大脑粉样蛋白水平升高可能表明未来与阿尔茨海默病相关的认知能力下降的风险增加.
- 了解这种关联对于早期发现和干预策略至关重要.
研究的目的:
- 量化认知能力下降的风险 在认知正常的个体中,
- 描述大脑粉样蛋白水平与认知轨迹之间的关系.
主要方法:
- 分析了阿尔茨海默病神经成像计划 (ADNI) 的445名认知正常参与者的纵向数据.
- 参与者根据基线大脑粉样蛋白水平 (正常或升高) 使用PET成像或CSF测定进行分类.
- 使用临床前阿尔茨海默氏症认知复合 (PACC),MMSE,CDR-Sum of Boxes和逻辑记忆延迟回忆进行了认知功能评估,平均随访时间为3.1年.
主要成果:
- 与正常的粉样蛋白相比,4年后,脑粉样蛋白水平升高的个体的认知表现明显下降.
- 这包括PACC,MMSE和CDR-Sum of Boxes得分的下降.
- 在4年后的逻辑记忆延迟回忆得分中没有观察到统计学意义上的差异.
结论:
- 在认知正常的个体中,脑粉样蛋白的升高与认知能力下降的可能性增加有关.
- 这些发现的临床意义和长期影响需要进一步研究.
- 需要进行更长的后续研究,以充分评估粉素对认知轨迹的影响.
更多相关视频
08:01Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
Published on: March 16, 2016
44.7K
08:29Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
14.7K
相关概念视频
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Cognitive Development During Adulthood
988
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
988
Dementia
614
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
614
Language and Cognition
891
Language serves as a bridge between ideas and communication, influencing how individuals perceive and interact with the world. Psychologists have long debated whether language shapes thought or vice versa. This discussion gained grip with Edward Sapir and Benjamin Lee Whorf in the 1940s, who proposed that language determines thought, a concept known as linguistic determinism. They suggested that the vocabulary and structure of a language influence how its speakers think and perceive reality.
891
Amyloid Fibrils
12.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.2K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
738
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
738
